Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bowers

Showing results (231-240 of 255) with videos related to

Pageof 26
Sort By:
Acta Neuropathologica|December 6, 2019
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2019
Germline <i>GPR161</i> Mutations Predispose to Pediatric MedulloblastomaMatthias Begemann, Sebastian M Waszak, Giles W Robinson, et al.
Journal of Lipid Research|February 16, 2006
Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4Christian R H Raetz, Teresa A Garrett, C Michael Reynolds, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 12, 2022
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in OncologyAmar Gajjar, Anita Mahajan, Mohamed Abdelbaki, et al.
Neuro-Oncology|April 13, 2019
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trialSanthosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyAmar Gajjar, Anita Mahajan, Tejus Bale, et al.
Neuro-Oncology|October 11, 2017
Pediatric low-grade gliomas: next biologically driven stepsDavid T W Jones, Mark W Kieran, Eric Bouffet, et al.
The Lancet. Oncology|October 27, 2012
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trialKent A Robertson, Grzegorz Nalepa, Feng-Chun Yang, et al.
Neuro-Oncology|September 30, 2016
Pediatric low-grade gliomas: implications of the biologic eraRoger J Packer, Stephan Pfister, Eric Bouffet, et al.
The Lancet. Oncology|April 12, 2021
Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization GroupDaniel C Bowers, Lisanne C Verbruggen, Leontien C M Kremer, et al.
Pageof 26

Showing results (231-240 of 255) with videos related to

Sort By:
Pageof 26
Acta Neuropathologica|December 6, 2019
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2019
Germline <i>GPR161</i> Mutations Predispose to Pediatric MedulloblastomaMatthias Begemann, Sebastian M Waszak, Giles W Robinson, et al.
Journal of Lipid Research|February 16, 2006
Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4Christian R H Raetz, Teresa A Garrett, C Michael Reynolds, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 12, 2022
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in OncologyAmar Gajjar, Anita Mahajan, Mohamed Abdelbaki, et al.
Neuro-Oncology|April 13, 2019
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trialSanthosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyAmar Gajjar, Anita Mahajan, Tejus Bale, et al.
Neuro-Oncology|October 11, 2017
Pediatric low-grade gliomas: next biologically driven stepsDavid T W Jones, Mark W Kieran, Eric Bouffet, et al.
The Lancet. Oncology|October 27, 2012
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trialKent A Robertson, Grzegorz Nalepa, Feng-Chun Yang, et al.
Neuro-Oncology|September 30, 2016
Pediatric low-grade gliomas: implications of the biologic eraRoger J Packer, Stephan Pfister, Eric Bouffet, et al.
The Lancet. Oncology|April 12, 2021
Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization GroupDaniel C Bowers, Lisanne C Verbruggen, Leontien C M Kremer, et al.
Pageof 26